Overview

Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3

Status:
Unknown status
Trial end date:
2008-07-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether fosinopril and losartan are effective in the treatment of patients with Chronic Kidney Disease(CKD) stage 3.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Shanghai Municipal Health Bureau
Treatments:
Fosinopril
Losartan
Criteria
Inclusion Criteria:

- Patients aged 18-75 years old

- Roll out secondary renal diseases

- Do not use steroids and immunosuppresive drugs

- ACEI/ARB treated patients should have 7-14 days wash out period,SiDBP< 110mmHg

- Willing and able to comprehend and give written informed consent

- Willing to follow-up regularly

Exclusion Criteria:

- Use steroids and immunosuppresive drugs

- Secondary renal diseases

- Acute cardio-cerebral diseases within 6 months

- Post renal transplantation

- Pregnant/Nursing women

- History of hypersensitivity to ACEI/ARB

- Refuse to join clinical trial